In the past couple of years, the global cell surface markers market has exhibited remarkable growth. Impelled by factors such as robust technological advances, automation of solutions, and simplification of data management in conjunction with increased steps taken to curb high expenditure incurred in the healthcare sector, the cell surface markers market is poised to grow at a positive 8.1% CAGR. According to Transparency Market Research, a leading research intelligence firm, in 2012 the market was valued at US$13.2 billion and is expected to reach US$23.03 billion by 2019.
Request a PDF Brochure with Report Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1516
Cell surface markers, which are molecules or antigens present within the plasma membrane of the cell, play a vital functional role in immunology. The markers are indispensable components that assist in categorization and identification of cells such as tumor cells, macrophages, lymphocytes, monocytes, and others directly corresponding to immunology. For a successful cell surface marker analysis, technologies such as hematology analyzers and cytometry are often resorted to. These technologies aid analysis on various samples such as blood, lymph, bone marrow, nodes, and other tissues. The main objective behind such new technologies and analysis is to simplify the methods of disease identification and diagnosis. Moreover, this method has also proved to be very helpful in sample preparation and drug discovery.
The market at present is propelled by the escalating need for prompt and rapid decision making for therapies. Meanwhile, increasing incidence of chronic diseases such as autoimmune disorders and cancer has also significantly contributed to the elevated demand for cell surface markers analysis worldwide. Research into cell surface markers has come a long way since its advent. Introduction of robust technologies in the field of study is expected to benefit end users greatly by increasing the scope of application of cell surface markers.
Multiple factors have come together to create a favorable environment for the cell surface markers market to thrive. The boost in market opportunities are expected to benefit companies looking forward to invest in developing automated systems and improving sample processing and analysis. In addition, the introduction of cost-effective instruments will further facilitate the growth of new entrants in the market.
One of the most crucial factors determining the growth of the global cell surface markers market is the propensity of players to invest in sophisticated technologies. It is only obvious that not all players in the market will exhibit an unequivocal stand with regards to investment. Reluctance on part of vendors to invest in sophisticated models of technology will emerge as a major concern for the market, curtailing its growth to an extent.
With an aim to counter market challenges and expand the market operations, the leading players are showcasing the benefits and uses of technological advances in conferences, trade shows, and seminars organized around the world. This is expected to create greater opportunities for manufacturers to capitalize on in the near future.
The global cell surface markers market can be segmented on the basis of application, reagents and instruments, and geography. The reagents and instrument categorization comprises hematology analyzers, flow cytometry, and reagents and kits. Hematology analyzers and flow cytometry are the two most commonly used systems. Flow cytometry has proven to be more efficient with respect to research and development and drug discovery than its contemporaries. This has resulted in a high demand for flow cytometry from pharmaceutical manufacturers and researchers. Furthermore, the availability of a wide array of flow cytometry in the market is also driving its demand.
Owing to the fact that a majority of leading players are located in North America, the region emerged as the largest market for cell surface markers. However, studies reveal that elevated healthcare awareness, growth in medical tourism, better affordability, and patient rehabilitation offered by emerging economies compared to developed countries will significantly propel the market for cell surface markers in the APAC and RoW regions in the foreseeable future.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.